MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6502-407-415$20.00
Mol Pharmacol 65:407-415, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Papapetropoulos, A.
Right arrow Articles by Sessa, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Papapetropoulos, A.
Right arrow Articles by Sessa, W. C.

Vanadate Is a Potent Activator of Endothelial Nitric-Oxide Synthase: Evidence for the Role of the Serine/Threonine Kinase Akt and the 90-kDa Heat Shock Protein

Andreas Papapetropoulos, David Fulton1, Michelle I. Lin, Jason Fontana, Timothy J. McCabe2, Stefan Zoellner, Guillermo García-Cardeña3, Zongmin Zhou, Jean-Phillipe Gratton4, and William C. Sessa

Department of Pharmacology and Vascular Cell Signaling and Therapeutics Program, Boyer Center for Molecular Medicine, Yale University School of Medicine, New Haven, Connecticut (A.P., D.F., M.I.L., J.F., S.F., G.G.-C., J.-P.G., W.C.S.) and "George P. Livanos" Laboratory, Evangelismos Hospital, Critical Care Department and Pulmonary Services, University of Athens, Athens, Greece (A.P., Z.Z.)

We investigated the molecular mechanisms of sodium vanadate (vanadate)-induced nitric oxide (NO) production. Exposure of bovine lung microvascular cells (BLMVEC) to vanadate increased the release of biologically active NO in endothelium/smooth muscle cocultures, as measured by the accumulation of its surrogate marker, cGMP. This release was sensitive to NO synthase (NOS) inhibition and was greater than that observed with ionomycin. Although calcium chelators (BAPTA, EGTA) inhibited basal and ionomycin-induced NO production, they failed to inhibit vanadate-induced NO release. Moreover, in the absence of calcium/calmodulin, cell lysates from vanadate-treated cells exhibited greater NOS activity compared with control cells. Vanadate activates the phosphoinositide3-kinase (PI3-K)/Akt pathway, which is known to increase endothelial NOS (eNOS) activity by direct phosphorylation of Ser-1179. Treatment of BLMVEC with vanadate resulted in phosphorylation of both Akt and endothelial NOS. In addition, wortmannin, a PI3-K inhibitor, blocked both the vanadate-induced phosphorylation of eNOS and the increase in cGMP accumulation. Similarly, adenovirus-mediated gene transfer of an activation deficient form of Akt (AA-Akt) blocked the release of NO brought about by vanadate. To further investigate the mechanism of action of vanadate, eNOS was immunoprecipitated and its association with proteins that alter eNOS activity was tested. Immunoblots demonstrated that the eNOS-caveolin interaction remained unaffected by vanadate, whereas vanadate promoted recruitment of the 90-kDa heat shock protein (hsp90) to eNOS. We conclude that vanadate causes NO release via a mechanism that involves Akt-induced eNOS phosphorylation and increased binding of the activator protein hsp90 to eNOS.


Received June 13, 2003; accepted September 29, 2003

Address correspondence to: Dr. Andreas Papapetropoulos, "George P. Livanos" Laboratory, Department of Critical Care and Pulmonary Services, University of Athens, Ploutarchou 3, Athens, Greece 10675. E-mail: apapapet{at}upatras.gr




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
F. Edlich, F. Erdmann, F. Jarczowski, M.-C. Moutty, M. Weiwad, and G. Fischer
The Bcl-2 Regulator FKBP38-Calmodulin-Ca2+ Is Inhibited by Hsp90
J. Biol. Chem., May 25, 2007; 282(21): 15341 - 15348.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Fulton, J. E. Church, L. Ruan, C. Li, S. G. Sood, B. E. Kemp, I. G. Jennings, and R. C. Venema
Src Kinase Activates Endothelial Nitric-oxide Synthase by Phosphorylating Tyr-83
J. Biol. Chem., October 28, 2005; 280(43): 35943 - 35952.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Martinez-Ruiz, L. Villanueva, C. G. de Orduna, D. Lopez-Ferrer, M. A. Higueras, C. Tarin, I. Rodriguez-Crespo, J. Vazquez, and S. Lamas
S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities
PNAS, June 14, 2005; 102(24): 8525 - 8530.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. Dimitropoulou, R. E. White, D. R. Ownby, and J. D. Catravas
Estrogen Reduces Carbachol-Induced Constriction of Asthmatic Airways by Stimulating Large-Conductance Voltage and Calcium-Dependent Potassium Channels
Am. J. Respir. Cell Mol. Biol., March 1, 2005; 32(3): 239 - 247.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics